One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.jmir.2019.03.113
Copy DOI Publication Date: Mar 1, 2019 | |
 Citations: 18 |
Affiliation: University of Louisville, Columbia University Irving Medical Center, Baylor University Medical Center, Cancer Institute (WIA), Duke University, University of Pennsylvania, Actinium Pharmaceuticals (United States), Memorial Sloan Kettering Cancer Center, Fred Hutch Cancer Center, West Virginia University, Saint Francis University, Ochsner Medical Center, Winneshiek Medical Center, Medical College of Wisconsin, Cornell UniversityA Phase 2 Study of Actinium-225 (225Ac)-lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
